Kaken Pharmaceutical Co Ltd
TSE:4521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
JP |
|
Yuuzoo Networks Group Corp
SGX:AFC
|
SG |
|
Sterling Check Corp
NASDAQ:STER
|
US |
|
C
|
Core One Labs Inc
CNSX:COOL
|
CA |
|
B
|
Ball Corp
F:BL8
|
US |
|
A
|
AmFIRST Real Estate Investment Trust
KLSE:AMFIRST
|
MY |
|
S
|
Suprema Inc
KOSDAQ:236200
|
KR |
|
bluebird bio Inc
NASDAQ:BLUE
|
US |
|
C
|
CPT Drives And Power PCL
SET:CPT
|
TH |
|
BOD Australia Ltd
ASX:BOD
|
AU |
|
AST SpaceMobile Inc
NASDAQ:ASTS
|
US |
|
Amphenol Corp
NYSE:APH
|
US |
|
Ambu A/S
OTC:AMBFF
|
DK |
|
P
|
Phoenix Asia Holdings Ltd
NASDAQ:PHOE
|
HK |
|
Tsodilo Resources Ltd
XTSX:TSD
|
CA |
|
P
|
Pelita Teknologi Global PT Tbk
IDX:CHIP
|
ID |
Dividends
Dividend Yield
Kaken Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Kaken Pharmaceutical Co Ltd
Payout Ratio
Kaken Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Kaken Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Kaken Pharmaceutical Co Ltd
| Average Annual Return | 1.05% |
| Standard Deviation of Annual Returns | 22.62% |
| Max Drawdown | -33% |
| Market Capitalization | 150B JPY |
| Shares Outstanding | 37 869 647 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Kaken Pharmaceutical Co Ltd's latest stock split occurred on Sep 28, 2015
The company executed a 1-for-2 stock split, meaning that for every 2 shares held, investors received 1 new share.
Before the split, Kaken Pharmaceutical Co Ltd traded at 5920 per share. Afterward, the share price was about 9398.2326.
The adjusted shares began trading on Sep 28, 2015. This was the only stock split in Kaken Pharmaceutical Co Ltd's history.
